{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T01:28:23Z","timestamp":1780709303517,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T00:00:00Z","timestamp":1524441600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Carlos Chagas Filho Foundation for Research Support of the State of Rio de Janeiro","award":["BRL 112.436,00"],"award-info":[{"award-number":["BRL 112.436,00"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13063-018-2623-6","type":"journal-article","created":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T08:19:35Z","timestamp":1524471575000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Chemoprophylaxis of leprosy with rifampicin in contacts of multibacillary patients: study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5194-2020","authenticated-orcid":false,"given":"Daiane Santos","family":"dos Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00e1dia Cristina","family":"Duppre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euzenir Nunes","family":"Sarno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta Olmo","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Sales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Augusto Da Costa","family":"Nery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton Oz\u00f3rio","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Ant\u00f4nio Bastos","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,23]]},"reference":[{"key":"#cr-split#-2623_CR1.1","unstructured":"1. World Health Organization. Weekly epidemiological record. 4 September 2015, 90th Year. No. 36, vol. 90"},{"key":"#cr-split#-2623_CR1.2","unstructured":"2. 2015. p. 461-76. http:\/\/www.who.int\/wer\/2015\/wer9036.pdf?ua=1 . Acessed 2 Feb 2017."},{"key":"#cr-split#-2623_CR2.1","unstructured":"3. World Health Organization. Weekly epidemiological record. 2 September 2016, 91st Year. No 35, vol. 91"},{"key":"#cr-split#-2623_CR2.2","unstructured":"4. 2016. p. 405-20. http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/249601\/WER9135.pdf;jsessionid=7C1587F799E5C75D7FBD3E0DDF2353E7?sequence=1 . Acessed 2 Feb 2017."},{"key":"2623_CR3","doi-asserted-by":"publisher","first-page":"g1136","DOI":"10.1136\/bmj.g1136","volume":"348","author":"DN Lockwood","year":"2014","unstructured":"Lockwood DN, Shetty V, Penna GO. Hazards of setting targets to eliminate disease: lessons from the leprosy elimination campaign. BMJ. 2014;348:g1136.","journal-title":"BMJ"},{"key":"2623_CR4","unstructured":"Ministry of Health. General detection rate of new cases of leprosy, states, Brazil. 2015. Source: Fonte: SINAN\/SVS\/MS 31\/05\/2016. http:\/\/portalarquivos.saude.gov.br\/images\/pdf\/2016\/julho\/07\/Taxa-de-detec----o-geral-de-casos-novos-dehansen--ase--estados--Brasil--2015..pdf . Accessed 2 Feb 2017."},{"issue":"7","key":"2623_CR5","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.trstmh.2008.04.015","volume":"102","author":"NC Duppre","year":"2008","unstructured":"Duppre NC, Camacho LA, da Cunha SS, Struchiner CJ, Sales AM, Nery JA, et al. Effectiveness of BCG vaccination among leprosy contacts: a cohort study. Trans R Soc Trop Med Hyg. 2008;102(7):631\u20138.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6","key":"2623_CR6","doi-asserted-by":"publisher","first-page":"e1711","DOI":"10.1371\/journal.pntd.0001711","volume":"6","author":"NC Duppre","year":"2012","unstructured":"Duppre NC, Camacho LAB, Sales AM, Illarramendi X, Nery JAC, et al. Impact of PGL-I seropositivity on the protective effect of BCG vaccination among leprosy contacts: a cohort study. PLoS Negl Trop Dis. 2012;6(6):e1711. https:\/\/doi.org\/10.1371\/journal.pntd.0001711 .","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"2623_CR7","first-page":"389","volume":"67","author":"A Bagshawe","year":"1989","unstructured":"Bagshawe A, Scott GC, Russell DA, Wigley SC, Merianos A, Berry G. BCG vaccination in leprosy: final results of the trial in Karimui, Papua New Guinea, 1963\u201379. Bull World Health Organ. 1989;67(4):389\u201399.","journal-title":"Bull World Health Organ"},{"issue":"7647","key":"2623_CR8","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/bmj.39500.885752.BE","volume":"336","author":"FJ Moet","year":"2008","unstructured":"Moet FJ, Pahan D, Oskam L, Richardus JH. Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial. BMJ. 2008;336(7647):761\u20134.","journal-title":"BMJ"},{"key":"2623_CR9","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/j.vaccine.2015.02.017","volume":"33","author":"RA Richardus","year":"2015","unstructured":"Richardus RA, Butlinb CR, Alamb K, Gelukc KKA, Richardus JH. Clinical manifestations of leprosy after BCG vaccination: an observational study in Bangladesh. Vaccine. 2015;33:1562\u20137.","journal-title":"Vaccine"},{"issue":"5","key":"2623_CR10","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1128\/JCM.41.5.1991-1995.2003","volume":"41","author":"S B\u00fchrer-S\u00e9kula","year":"2003","unstructured":"B\u00fchrer-S\u00e9kula S, Smits HL, Gussenhoven GC, van Leeuwen J, Amador S, Fujiwara T, Klatser PR, Oskam L. Simple and fast lateral flow test for classification of leprosy patients and identification of contacts with high risk of developing leprosy. J Clin Microbiol. 2003;41(5):1991\u20135.","journal-title":"J Clin Microbiol"},{"issue":"11","key":"2623_CR11","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1128\/CVI.00299-07","volume":"14","author":"MS Duthie","year":"2007","unstructured":"Duthie MS, Goto W, Ireton GC, Reece ST, Cardoso LP, Martelli CM, Stefani MM, Nakatani M, de Jesus RC, Netto EM, Balagon MV, Tan E, Gelber RH, Maeda Makino Y, Hoft DM, Reed SG. Use of protein antigens for the early serological diagnosis of leprosy. Clin Vaccine Immunol. 2007;14(11):1400\u20138.","journal-title":"Clin Vaccine Immunol"},{"issue":"7","key":"2623_CR12","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1128\/JCM.00512-09","volume":"47","author":"AN Martinez","year":"2009","unstructured":"Martinez AN, Lahiri R, Pittman TL, Scollard D, Truman R, Moraes MO, Williams DL. Molecular determination of Mycobacterium leprae viability by use of real time PCR. J Clin Microbiol. 2009;47(7):2124\u201330.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"2623_CR13","doi-asserted-by":"publisher","first-page":"e1354","DOI":"10.1371\/journal.pntd.0001354","volume":"5","author":"AN Martinez","year":"2011","unstructured":"Martinez AN, Ribeiro-Alves M, Sarno EN, Moraes MO. Evaluation of qPCR-based assays for leprosy diagnosis directly in clinical specimens. PLoS Negl Trop Dis. 2011;5(10):e1354.","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"2623_CR14","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1093\/infdis\/164.5.990","volume":"164","author":"EP Sampaio","year":"1991","unstructured":"Sampaio EP, Moreira AL, Kaplan G, Alvim MF, Duppre NC, Miranda CF, Sarno EN. Mycobacterium leprae-induced interferon-gamma production by household contacts of leprosy patients: association with the development of active disease. J Infect Dis. 1991;164(5):990\u20133.","journal-title":"J Infect Dis"},{"key":"2623_CR15","unstructured":"Rifampina Package Insert. http:\/\/www.anvisa.gov.br\/datavisa\/fila_bula\/frmVisualizarBula.asp?pNuTransacao=9457492015&pIdAnexo=2916409 . Accessed 30 Aug 2016."},{"key":"2623_CR16","unstructured":"Ministry of Health. Epidemiological Surveillance Guide, Ministry of Health, 2009. 2009. Available at: http:\/\/bvsms.saude.gov.br\/bvs\/publicacoes\/guia_vigilancia_epidemiologica_7ed.pdf . Acessed 2 Feb 2017."},{"key":"2623_CR17","first-page":"255","volume":"34","author":"DS Ridley","year":"1966","unstructured":"Ridley DS, Jopling WH. Classification os Leprosy according to immunity- a Five group system. Int J Lepr Other Mycobat. 1966;34:255\u201373.","journal-title":"Int J Lepr Other Mycobat"},{"key":"2623_CR18","volume-title":"Guide for the Control of Leprosy","author":"Ministry of Health","year":"2002","unstructured":"Ministry of Health. Guide for the Control of Leprosy. Bras\u00edlia: Ministry of Health, Secretariat of Health Policies, Department of Attention; 2002."},{"key":"2623_CR19","unstructured":"Ministry of Health. Health Surveillance Secretariat. 2010 Guide to technical procedures on leprosy. Brasilia. http:\/\/bvsms.saude.gov.br\/bvs\/publicacoes\/guia_procedimentos_tecnicos_corticosteroides_hanseniase ."},{"key":"2623_CR20","volume-title":"Analysis alternatives for a binary endpoint in cross-sectional and longitudinal studies. Dissertation presented to the Federal University of Pelotas as part of the requirements of the Postgraduate Program in Epidemiology, Master\u2019s Degree","author":"VN Hirakata","year":"1999","unstructured":"Hirakata VN. Analysis alternatives for a binary endpoint in cross-sectional and longitudinal studies. Dissertation presented to the Federal University of Pelotas as part of the requirements of the Postgraduate Program in Epidemiology, Master\u2019s Degree, 1999."},{"key":"2623_CR21","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"E Kaplan","year":"1958","unstructured":"Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457\u201381.","journal-title":"J Am Stat Assoc"},{"key":"2623_CR22","doi-asserted-by":"crossref","unstructured":"Piantadosi S. Clinical Trials - A Methodologic Perspective. Second Edition.2005 Wiley Interscience. Wiley Publication.","DOI":"10.1002\/0471740136"},{"key":"2623_CR23","unstructured":"Hintze J. PASS 11. NCSS, LLC. Kaysville; 2011. https:\/\/www.ncss.com\/download\/pass\/updates\/pass11\/ . Acessed 2 Feb 2017."},{"key":"2623_CR24","unstructured":"Ministry of Health. Chemoprophylaxis of contacts of leprosy patients with rifampicin in a single dose\u2014Report of Recommendation. CONITEC June 2015, n \u00b0 165 MS \/ CGHDE \/ DEVIT \/ SVS General Coordination of Leprosy and Eliminating Diseases - PEP-HANS Brazil Operation of Post-Exposure Prophylaxis with immuno and chemoprophylaxis for leprosy contacts. 2016."},{"key":"2623_CR25","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1186\/1471-2334-13-456","volume":"13","author":"RA Richardus","year":"2013","unstructured":"Richardus RA, Alam K, Paham D, Feenstra SG, Geluk A, Richardus JH. The combined effect of chemoprophylaxis with single dose rifampicin and immunoprophylaxis with BCG to prevent leprosy in contacts of newly diagnosed leprosy cases: a cluster randomized controlled trial (MALTALEP study). BMC Infect Dis. 2013;13:456.","journal-title":"BMC Infect Dis"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-2623-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-018-2623-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-2623-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T17:27:45Z","timestamp":1571246865000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-018-2623-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,23]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2623"],"URL":"https:\/\/doi.org\/10.1186\/s13063-018-2623-6","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,23]]},"assertion":[{"value":"6 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The present study was approved by the Ethics Committee of the Oswaldo Cruz Institute (IOC\/FIOCRUZ) under the registration numbers CAAE 41678415.8.0000.5248 (19 June 2015) and CAEE 53520016.4.0000.5248 (17 January 2017), and registered on the platforms of the Brazilian Registry of Clinical Trials (ReBEC) under number RBR-69QK5P on 1 June 2017. The study follows the standards established in the Declaration of Helsinki, Good Clinical Practice Guidelines and Document of the Americas (Pan American Health Organization, 2005). It abides by the Brazilian ethical norms (Resolution CNS No. 466\/12 and Resolution CNS No. 510\/16) regulating research on human beings. Candidates are duly informed that their participation in the study is totally voluntary and that they may leave the study without any restrictions in the health care they receive from then on. Support during the follow-up period to manage the occurrence of any adverse events and evaluate any suspected cases of leprosy is assured. The study procedures will ensure the privacy rights of all participants (locked file cabinets and free access to the study dataset). The results of this research will only be presented in an aggregate way to prevent any personal identification of the participants.A data monitoring committee comprising independent experts in leprosy control, clinical research, and statistics will oversee the study development. They will receive timely reports of protocol amendments, incidents, and adverse events and data analysis. The committee\u2019s meetings will be convened to assess interim and final analyses and their results.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"244"}}